Brought to you by:
First-in-human study of Pounce thrombectomy system in acute iliofemoral DVT demonstrates 12-month PTS rate of 18%
Twelve-month outcomes from the Pounce venous thrombectomy system (Vetex Medical) first-in-human study evaluating its use in the treatment of acute iliofemoral deep vein thrombosis (DVT) recently published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) demonstrated an…
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data presentations
At the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK), Andrew Bradbury (University of Birmingham, Birmingham, UK) and the BASIL-3 team of triallists will address the pressing question of which endovascular strategy wins in the disputed femoropopliteal segment. The…
FDA Breakthrough Device designation granted for DynamX BTK for use in CLTI treatment below the knee
Elixir Medical has announced Breakthrough Device designation by the Food and Drug Administration (FDA) for its novel DynamX BTK System, an implant for use in the treatment of narrowed or blocked vessels below-the-knee (BTK) in patients with chronic limb-threatening ischemia…
Personalized, precision medicine is key to the future of aortic repair
Predicting longevity in patients who may be candidates for aortic repair is challenging. This, coupled with a high and unchanging long-term postoperative mortality rate, begs the question: are patients living long enough to benefit from aortic repair? Bijan Modarai (King’s…
Bentley, Cook Medical enter US distribution agreement for BeBack device
Cook Medical and Bentley today announced a distribution agreement for the BeBack crossing catheter in the U.S., with Cook assuming commercial responsibilities for the Bentley product in the coming months. The BeBack device is designed for steering through chronic total…
SCVS 2024: Bismuth becomes 2024–25 Society for Clinical Vascular Surgery president
Jean Bismuth, MD, took over as Society for Clinical Vascular Surgery (SCVS) president during the organization’s 51st Annual Symposium in Scottsdale, Arizona (March 16–20). The new University of South Florida chief of vascular surgery followed M. Ashraf Mansour, MD, academic…
Hans-Henning Eckstein: 1955–2024
Hans-Henning Eckstein, the vascular surgeon who played a leading role in the SPACE and SPACE 2 randomised controlled trials on the treatment of carotid stenosis and founder of the Munich Vascular Conference (MAC), died on 24 February at the age…
First patient enrolled in IDE study of Aquedeon Medical’s Duett vascular graft system
Aquedeon Medical has announced the initiation of an investigational device exemption (IDE) clinical trial to study the Duett vascular graft system. A press release reveals that, this February, the first enrolled patient underwent open surgical aortic arch reconstruction at the…
Multi-society PAD Pulse Alliance aims to highlight importance of patient education
Society for Vascular Surgery (SVS) experts are spearheading initiatives as part of the multispecialty PAD Pulse Alliance and its Get a Pulse on PAD public awareness campaign aimed at educating and raising awareness of the risk factors and potential symptoms…
VRIC 2024 to hear from leading light on role of immunity and inflammation in atherosclerosis
Filip Swirski, PhD, a leading figure in cardiovascular immunology research, will deliver this year’s Alexander W. Clowes Distinguished Lecture at the 2024 Vascular Research Initiatives Conference (VRIC). Swirski, currently the director of the Cardiovascular Research Institute at the Icahn School…